• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NIHR launches first two translational partnerships in U.K.

NIHR launches first two translational partnerships in U.K.

October 11, 2011
CenterWatch Staff

NIHR translational research partnerships bring together investigators at the U.K.’s leading academic and NHS centers to support collaboration with the life sciences industry in early and exploratory development of new drugs and other interventions.

The research centers that make up the partnerships have been selected to work together based on their proven ability to deliver in experimental medicine and translational research. As members of a partnership, each center has committed to work with industry through a consistent point of contact provided by the NIHR office for clinical research infrastructure (NOCRI).

NIHR has launched the first two translational research partnerships, focusing on joint and related inflammatory diseases, including rheumatoid arthritis, osteoarthritis and synovitis, and inflammatory respiratory disease including asthma, allergy, COPD, cystic fibrosis, acute lung injury and respiratory infection.

Translational research partnerships offer an internationally unique approach to support open innovation and collaboration with the life sciences industries.  Collectively they bring together recognized experience in current exploratory development protocols, expertise in pathophysiology and disease mechanisms and expertise in modeling. They enable technologies and infrastructure, including imaging, biobanks and accredited laboratory facilities. They also offer cohorts of well-characterized patients available for clinical development studies.

Further partnerships will be developed. NOCRI is working with a range of stakeholders to assess which disease and theraputic areas would benefit from this approach. NIHR biomedical research centers and units provide the bedrock of the first two NIHR partnerships and will form the basis of future partnerships.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing